GO
| HSI1 | 23,094.83 | 0.00 | -- |
| HSCEI1 | 7,791.63 | 0.00 | -- |
| Back Zoom + Zoom - Block Traded | |
|
2026-10-27 12:41:52 US stocks closed higher overnight (26th), with the three major indices advancing. Anthropic's IPO filing boosted market sentiment, while chip and semiconductor stocks rose. Investors are focusing on this week's Federal Reserve rate meeting and awaiting news announcements after the completion of the Fifth Plenary Session of the 20th CPC Central Committee. The HSI opened 48 pts higher this morning (27th), once gaining about 100 pts before selling pressure emerged and pushed the market into negative territory. The HSI closed the half-day at 23,180 pts, down 31 pts or 0.14%, with half-day turnover at HKD88.685 billion. The HSCEI stood at 7,774 pts, down 27 pts or 0.35%, while the HSTECH closed at 3,827 pts, down 29 pts or 0.77%. Major tech stocks were broadly under pressure. XIAOMI-W (01810.HK) slumped 4.16%; NTES (09999.HK) fell 3.19%; MEITUAN-W (03690.HK) dropped 2.36%; TENCENT (00700.HK) rose 0.31%; and BABA-W (09988.HK) edged down 0.2%. Among blue chips, LENOVO GROUP (00992.HK) rebounded 5.8%, making it the best-performing blue chip in the morning session. LI NING (02331.HK) gained 5.45% after brokers said the special dividend was a positive surprise. HSBC HOLDINGS (00005.HK) rose 0.63% ahead of its noon results announcement. LONGFOR GROUP (00960.HK) closed down 4.94% at HKD4.715, hitting another record trough. CSPC PHARMA (01093.HK) and HANSOH PHARMA (03692.HK) each fell more than 3%. CATL (03750.HK) dropped 2.8% after Morgan Stanley downgraded the company to "Equalweight" and slashed its TP by nearly 45%. Hong Kong-listed chip stocks tracked gains in overseas markets. SMIC (00981.HK) rose 1.22%; HUA HONG GRACE (01347.HK) gained 2.88%; MONTAGE TECH (06809.HK) advanced 4.57%; ILUVATAR COREX (09903.HK) climbed nearly 2%; and GIGADEVICE (03986.HK) rose 1.8%. Anthropic's IPO filing lifted sentiment across the AI sector. Z.AI (02513.HK) surged 9.4%; MINIMAX-W (00100.HK) gained 1.95%; and XUNCE (03317.HK) rose 1.84%. Some AI hardware stocks were also boosted, with KB LAMINATES (01888.HK) and KINGBOARD HLDG (00148.HK) each rising more than 5%; ZJ INNOLIGHT (03308.HK) gained 3.19%; YOFC (06869.HK) advanced 4.89%; and CIG (06166.HK) rose 3.56%. Among individual stocks, CHINA TRAVEL HK (00308.HK) reversed losses at midday to fall 3.93% after opening higher, although Citi viewed positively the company's spin-off of its Hong Kong and Macau cultural tourism business. YUE YUEN IND (00551.HK), which issued a profit warning, dropped 8.74%, although UBS said its third-quarter net profit met expectations. SHIMAO GROUP (00813.HK), after plunging 19.6% in the previous session, continued to decline this morning and closed the half-day at HKD0.04, down 11.11%, with turnover of HKD2.4898 million. Its offshore debt instruments recently triggered a default event, with outstanding principal exceeding USD9 billion. EASTROC (09980.HK) fell 2.2% at midday, while MENGNIU DAIRY (02319.HK) dropped nearly 3%, after both companies separately announced the end of cooperation with French football star Kylian Mbappe. DUALITYBIO-B (09606.HK) closed the half-day at HKD104.2, down 29.36%, with turnover surging to HKD594 million. The company announced that the Phase III clinical trial DYNASTY-BREAST02 for pacmilimab trastuzumab had reached its primary study endpoint. The results showed that among HR+/HER2-low metastatic breast cancer patients who experienced disease progression after prior endocrine therapy and had not received chemotherapy, pacmilimab trastuzumab achieved a statistically significant moderate improvement in progression-free survival compared with the investigator's choice chemotherapy control group. As of the interim analysis, data for the secondary endpoint of overall survival had not yet matured. (mn/da)~ AASTOCKS Financial News Website: www.aastocks.com This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. | |